Network Point-of-Care Glucose Testing Market size is expected to reach USD 1.6 billion by 2028
Network Point-of-Care Glucose Testing Industry Overview
The global network point-of-care glucose testing market size is expected to reach USD 1.6 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 3.9% from 2021 to 2028. Increasing demand for safe and accurate remote patient monitoring options and the need for data-based treatment regimens are major factors driving the market. The integration of advanced technologies including Bluetooth Low Energy (BLE) and Infrared is expected to fuel the market growth in the upcoming years.
Network Point-of-Care Glucose Testing Market Segmentation
Grand View Research has segmented the global network point-of-care glucose testing market on the basis of product and region:
Based on the Product Insights, the market is segmented into i-STAT, Accu-Chek Inform II, StatStrip, HemoCue, CareSens Expert Plus and BAROzen H Expert Plus
- The Accu-Chek Inform II held the largest revenue share of over 45.0% in 2020. The Accu-Chek Inform II glucose meter is designed for in-vitro diagnostic applications aiding in the determination of blood glucose levels. This glucose meter monitors blood glucose levels in capillary, venous, neonatal and arterial, and whole blood samples. Healthcare professionals adopt Accu-Chek Inform II as it serves as a bedside system that aids in the measurement of glucose and automates the management of data generated by blood glucose tests.
- i-STAT is expected to expand at a CAGR of 4.2% over the forecast period. i-STAT portable clinical analyzer developed by Abbott is one of the POC analyzers used at patients’ bedside for critical care tests for electrolytes, coagulation, blood gases, and metabolites. The device is equipped with a number of testing cartridges for monitoring different sets of analytes, which eliminates the need for several analyzers for different analytes.
Network Point-of-Care Glucose Testing Regional Outlook
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Key Companies Profile & Market Share Insights
The market is currently dominated by a few major players. Increasing demand and technological advancements are expected to attract new entrants in upcoming years. The integration of advanced data transfer technologies, including BLE and Infrared, is anticipated to aid in new product launches.
Some prominent players in the global network point-of-care glucose testing market include:
- Hoffmann-La Roche Ltd.
- Abbott
- Nova Biomedical
- Bayer AG/Ascensia diabetes care holdings AG
- Danaher
Order a free sample PDF of the Network Point-of-Care Glucose Testing Market Intelligence Study, published by Grand View Research.
Comments
Post a Comment